Inventor · disambiguated record
Jinichi Yonemori
Also filed as: YONEMORI JINICHI
13 granted patents·39 citations·filing 2004–2021
89Inventor score
Top patents by PatentIndex Score
13 records- 0195US9878989B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 30, 2018·7 cites·2 claims
- 0292US10428056B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·4 cites·2 claims
- 0391US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0491US10548899B2Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activityTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 4, 2020·7 cites·11 claims
- 0590US10323027B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 18, 2019·4 cites·6 claims
- 0688US10435399B2HDAC6 inhibitory heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 8, 2019·5 cites·17 claims
- 0785US10899752B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 26, 2021·1 cites·11 claims
- 0874US10548877B2Aromatic ring compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Feb 4, 2020·2 cites·11 claims
- 0971US8008525B2Receptor function regulating agentTAKEDA PHARMACEUTICAL·Filed 2004·Granted Aug 30, 2011·5 cites·5 claims
- 1066US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 1152US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 1249US12084436B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 10, 2024·0 cites·16 claims
- 1346US10131653B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 20, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Jinichi Yonemori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →